The latest news from VIVA Physicians
Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.
News & Updates
The VEINS Announces 2021-22 Scientific Committee
VIVA Physicians is pleased to announce four new appointments to the Scientific Committee for The VEINS at VIVA. Serving a two-year term, this multidisciplinary group of experts will work with Course Director Maureen Kohi, MD, to develop comprehensive, novel, and balanced curricula for today's venous specialists.
Now i ...
The VEINS 2020 Preview
Raghu Kolluri, MS, MD VIVA Board of Directors | The VEINS Course Director
For 10 years, The VEINS has met its mission of providing unparalleled venous education. Annually, the conference has expanded and adapted to reach an ever-growing audience of healthcare providers, both in numbers and the diversity of specialties ...
4-Year DCB Mortality Across ILLUMENATE RCTs
Presented by Sean Lyden, MD
The Stellarex (Philips) drug-coated balloon (DCB) is a unique low-dose 2mcg/dl paclitaxel-coated balloon using polyethylene glycol as an excipient. The Stellarex DCB has been studied in 7 above-the-knee popliteal studies in over 2900 patients treated with independent clinical event committe ...
2-Year Outcomes of a Multi-Centre Study on Infrapopliteal Bioresorbable Vascular Scaffold
Presented by Steven Kum, MD
Chronic Limb Threatening Ischemia (CLTI) continues to plague many patients worldwide and is associated with complex comorbidities, poor vessel patency, and major lower extremity amputations. Plain balloon angioplasty is still the mainstay of treatment although metallic drug-eluting stents h ...
24-Month Outcomes from the DETOUR 1 Trial for Percutaneous Femoropopliteal Bypass
Presented by Ehrin Armstrong, MD
The DETOUR1 Trial was designed to evaluate the safety and effectiveness of the Detour System for percutaneous fem-pop bypass, which received FDA’s Breakthrough Device Designation. Using the novel PQ Crossing Device and a series of specially designed Torus Stent Grafts, the Detour proced ...